ATE291625T1 - Streptococcus toxinmutanten und verfahren zu deren anwendung - Google Patents

Streptococcus toxinmutanten und verfahren zu deren anwendung

Info

Publication number
ATE291625T1
ATE291625T1 AT96921589T AT96921589T ATE291625T1 AT E291625 T1 ATE291625 T1 AT E291625T1 AT 96921589 T AT96921589 T AT 96921589T AT 96921589 T AT96921589 T AT 96921589T AT E291625 T1 ATE291625 T1 AT E291625T1
Authority
AT
Austria
Prior art keywords
spe
toxin
vaccine
toxins
wild type
Prior art date
Application number
AT96921589T
Other languages
English (en)
Inventor
Patrick M Schlievert
Manuela Roggiani
Jennifer Stoehr
Douglas Ohlendorf
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Application granted granted Critical
Publication of ATE291625T1 publication Critical patent/ATE291625T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96921589T 1995-06-07 1996-06-07 Streptococcus toxinmutanten und verfahren zu deren anwendung ATE291625T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48026195A 1995-06-07 1995-06-07
PCT/US1996/010252 WO1996040930A1 (en) 1995-06-07 1996-06-07 Mutants of streptococcal toxin a and methods of use

Publications (1)

Publication Number Publication Date
ATE291625T1 true ATE291625T1 (de) 2005-04-15

Family

ID=23907283

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921589T ATE291625T1 (de) 1995-06-07 1996-06-07 Streptococcus toxinmutanten und verfahren zu deren anwendung

Country Status (12)

Country Link
US (3) US6632441B2 (de)
EP (2) EP1538208A3 (de)
JP (1) JPH11514844A (de)
KR (1) KR100456594B1 (de)
AT (1) ATE291625T1 (de)
AU (1) AU723116B2 (de)
CA (1) CA2221480A1 (de)
DE (1) DE69634510T2 (de)
DK (1) DK0832241T3 (de)
ES (1) ES2239332T3 (de)
PT (1) PT832241E (de)
WO (1) WO1996040930A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW517061B (en) * 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use
EP0946730B1 (de) 1996-12-06 2006-03-08 Regents Of The University Of Minnesota Mutanten von streptococcaltoxin c und verfahren zu deren anwendung
US6774218B2 (en) 1996-12-06 2004-08-10 Regents Of The University Of Minnesota Mutants of streptococcal toxin C and methods of use
ATE346860T1 (de) 1996-12-06 2006-12-15 Univ Minnesota Mutanten von streptococcaltoxinen und vefahren zu deren anwendung
US6075119A (en) * 1997-04-07 2000-06-13 The Rockefeller University Peptides useful for reducing symptoms of toxic shock syndrome
US7087235B2 (en) * 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
US6872394B1 (en) 1997-12-02 2005-03-29 Idaho Research Foundation, Inc. Non-toxic immune stimulating enterotoxin compositions
JP2003517445A (ja) * 1998-10-07 2003-05-27 ザ ロックフェラー ユニバーシティー 毒性ショック症候群および敗血症性ショックの兆候を減少させるのに有用なペプチド
US20040236082A1 (en) * 2001-04-13 2004-11-25 Marshall Matthew J. Modified staphylococcal enterotoxins and expression systems therefore
SE0102327D0 (sv) * 2001-06-28 2001-06-28 Active Biotech Ab A novel engineered superantigen for human therapy
US20070178113A1 (en) * 2005-11-22 2007-08-02 Backstrom B T Superantigen conjugate
EP2147015A4 (de) 2007-04-13 2011-01-26 Univ Oklahoma State Mutanten von cholesterinabhängigen cytolysinen und verwendungen davon
RU2380316C1 (ru) * 2008-10-13 2010-01-27 Закрытое акционерное общество "Макполимер" Способ получения органоглины
BR112016030008A2 (pt) 2014-06-27 2017-10-24 Abbott Lab método para a detecção de infecção por pegivirus humano 2 em um indivíduo, para a detecção de ácido nucleico de pegivirus humano 2 e para a detecção de pegivirus humano 2 em uma amostra, e, composição
SMT202400482T1 (it) 2014-11-21 2025-01-14 The Board Of Regents Of Theuniversity Of Oklahoma Mutanti della pneumolisina e metodi per relativo uso
CN109195988B (zh) 2016-01-10 2023-12-01 尼奥克斯医疗有限公司 用于增强超抗原介导的癌症免疫疗法效力的方法和组合物
WO2020230142A1 (en) 2019-05-15 2020-11-19 Neotx Therapeutics Ltd. Cancer treatment
WO2022074464A2 (en) 2020-03-05 2022-04-14 Neotx Therapeutics Ltd. Methods and compositions for treating cancer with immune cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784948A (en) * 1983-08-10 1988-11-15 The Rockefeller University Production of streptococcal m protein immunogens and molecular probes
US5336598A (en) 1989-11-15 1994-08-09 National Jewish Center For Immunology And Respiratory Medicine Method for diagnosing a superantigen caused pathologial condition via assay of T-cells
US5298396A (en) 1989-11-15 1994-03-29 National Jewish Center For Immunology And Respiratory Medicine Method for identifying T cells disease involved in autoimmune disease
EP0626805A4 (en) 1992-01-28 1995-12-06 Nat Jewish Ct Immun & Respirat Protective effects of mutated superantigens.

Also Published As

Publication number Publication date
ES2239332T3 (es) 2005-09-16
US6632441B2 (en) 2003-10-14
EP1538208A2 (de) 2005-06-08
EP0832241A1 (de) 1998-04-01
US6870042B1 (en) 2005-03-22
EP0832241B1 (de) 2005-03-23
AU6278296A (en) 1996-12-30
PT832241E (pt) 2005-08-31
AU723116B2 (en) 2000-08-17
US20020054887A1 (en) 2002-05-09
DE69634510D1 (de) 2005-04-28
DK0832241T3 (da) 2005-08-01
DE69634510T2 (de) 2006-01-26
KR100456594B1 (ko) 2005-06-17
EP1538208A3 (de) 2007-05-23
JPH11514844A (ja) 1999-12-21
US20060039925A1 (en) 2006-02-23
CA2221480A1 (en) 1996-12-19
KR19990022750A (ko) 1999-03-25
WO1996040930A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
ATE291625T1 (de) Streptococcus toxinmutanten und verfahren zu deren anwendung
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
BR9608500A (pt) Utilização de pelo menos um extrato de pelo menos uma bactéria filamentosa não fotossintética composição cosmética ou farmacêutica e processo de tratamento cosméstico
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
DE122012000001I1 (de) Humane antikorper gegen CTLA-4 und deren verwendungen.
ATE319830T1 (de) Mutanten von streptococcaltoxin c und verfahren zu deren anwendung
ATE346860T1 (de) Mutanten von streptococcaltoxinen und vefahren zu deren anwendung
ATE226947T1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung
ES2164684T3 (es) Uso de antagonistas de taquiquininas en el tratamiento de emesis.
DE69419966D1 (de) Impstoff gegen Streptococcus suis-Infektion
WO1996018646A3 (en) Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
ATE186731T1 (de) Anomere fluorribosylamine
DE69822870D1 (de) Verfahren zur desmethylierung von erythromycinen und deren derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0832241

Country of ref document: EP

REN Ceased due to non-payment of the annual fee